S&P 500
$5,802.82
-0.7%
-$39.19
DJI
$41,603.07
-0.6%
-$256.02
NASDAQ
$18,737.21
-1.0%
-$188.53
Bitcoin
108,440.00
-0.0%
-32.58
AAPL
$195.55
-2.9%
-$5.81
AMZN
$201.33
-0.9%
-$1.77
GOOG
$169.68
-1.3%
-$2.30
META
$627.70
-1.4%
-$8.87
MSFT
$451.11
-0.8%
-$3.75
NVDA
$131.48
-1.0%
-$1.36
TSLA
$339.93
-0.3%
-$1.11
Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights
Mar 10, 2025
by Keith Speights
Why Recursion Pharmaceuticals Stock Is Sinking Today
Mar 6, 2025
by Keith Speights
Investing in Biotech Stocks in 2025
![Trump at White House podium. Official White House Photo by D. Myles Cullen. [MConverter.eu]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F809069%2Ftrump-at-white-house-podium-official-white-house-photo-by-d-myles-cullen-mconvertereu.jpg&op=resize&w=165&h=104)
Feb 28, 2025
by Keith Speights
How to Invest in Tilray Stock
Feb 26, 2025
by Keith Speights
What Is a Tax Exemption?
Feb 26, 2025
by Keith Speights
Why Madrigal Pharmaceuticals Stock Is Soaring Today
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.